IE36030B1 - Anti-inflammatory preparations - Google Patents

Anti-inflammatory preparations

Info

Publication number
IE36030B1
IE36030B1 IE1414/71A IE141471A IE36030B1 IE 36030 B1 IE36030 B1 IE 36030B1 IE 1414/71 A IE1414/71 A IE 1414/71A IE 141471 A IE141471 A IE 141471A IE 36030 B1 IE36030 B1 IE 36030B1
Authority
IE
Ireland
Prior art keywords
coprecipitate
inflammatory
lignosulphonate
nov
inflammatory agent
Prior art date
Application number
IE1414/71A
Other versions
IE36030L (en
Original Assignee
Robins Co Inc A H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robins Co Inc A H filed Critical Robins Co Inc A H
Publication of IE36030L publication Critical patent/IE36030L/en
Publication of IE36030B1 publication Critical patent/IE36030B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

1345358 Anti-inflammatory preparations A H ROBINS CO Inc 8 Nov 1971 [16 Nov 1970] 51726/71 Heading A5B Anti-inflammatory preparations effective in preventing gastric irritation and bleeding of the gastric mucosa comprise a coprecipitate of an anti-inflammatory agent, such as aspirin, phenylbutazone or indomethacin, and a lignosulphonic acid or a salt thereof such as the ammonium, sodium, potassium, calcium, magnesium or lithium salt. The coprecipitate may be formed by acidifying an aqueous basic solution of an anti-inflammatory agent and a lignosulphonate and isolating the coprecipitate, e.g. by filtration or by spray drying. Pharmaceutical compositions for oral administration in the form of tablets or capsules comprise the coprecipitate and a carrier. The coprecipitate may comprise from 2 to 10% by weight of lignosulphonate. Suitable lignosulphonates are methanol-soluble or are those sold under the Trade Mark "Peritan". [GB1345358A]
IE1414/71A 1970-11-16 1971-11-09 Anti-inflammatory preparations IE36030B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8999970A 1970-11-16 1970-11-16

Publications (2)

Publication Number Publication Date
IE36030L IE36030L (en) 1972-05-16
IE36030B1 true IE36030B1 (en) 1976-08-04

Family

ID=22220596

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1414/71A IE36030B1 (en) 1970-11-16 1971-11-09 Anti-inflammatory preparations

Country Status (16)

Country Link
AT (1) AT313468B (en)
AU (1) AU461558B2 (en)
BE (1) BE775255A (en)
BR (1) BR7107569D0 (en)
CA (1) CA994241A (en)
CH (1) CH557177A (en)
DE (1) DE2156915A1 (en)
DK (1) DK132485C (en)
ES (2) ES397035A1 (en)
FI (1) FI51048C (en)
FR (1) FR2113976B1 (en)
GB (1) GB1345358A (en)
IE (1) IE36030B1 (en)
IL (1) IL38003A (en)
NL (1) NL7115198A (en)
ZA (1) ZA717652B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1335259C (en) * 1989-03-31 1995-04-18 Makoto Machida Composition of spent liquor from pulping process for antiviral medicine

Also Published As

Publication number Publication date
FR2113976A1 (en) 1972-06-30
BE775255A (en) 1972-03-01
DK132485C (en) 1976-05-17
AU3492871A (en) 1973-05-03
DE2156915A1 (en) 1972-05-31
GB1345358A (en) 1974-01-30
FR2113976B1 (en) 1975-10-31
NL7115198A (en) 1972-05-18
CH557177A (en) 1974-12-31
BR7107569D0 (en) 1973-08-16
FI51048B (en) 1976-06-30
AT313468B (en) 1974-02-25
IL38003A (en) 1974-06-30
IE36030L (en) 1972-05-16
AU461558B2 (en) 1975-05-29
ES422331A1 (en) 1976-06-01
ES397035A1 (en) 1975-03-01
CA994241A (en) 1976-08-03
IL38003A0 (en) 1971-12-29
FI51048C (en) 1976-10-11
ZA717652B (en) 1972-10-25
DK132485B (en) 1975-12-15

Similar Documents

Publication Publication Date Title
IE45256L (en) Quinazolone derivatives
IL49911A (en) 5-benzoyl-pyrrole-2-acetic acid derivatives, their preparation and pharmaceutical compositions containing them
GB1388358A (en) Taste-improving formulations of oral penicillins
IE45439L (en) Penicillanic acid derivatives
GB1298494A (en) Phenylethanolamine derivatives
ES427079A1 (en) Phenothiazine derivatives, compositions thereof and methods of preparation thereof
GB1271466A (en) Thiocarbamic acid derivatives
IL46893A (en) Pharmaceutical compositions containing 4-oxo- benzopyran-6-etanol or 6-acetic acid derivatives, certain novel compounds of this type and their preparation
JPS5781409A (en) External plaster
IE36030L (en) Anti-inflammatory preparations
GB1411701A (en) Compositions containing compounds of the eburnane structure
JPS5661311A (en) Thial amide or prolonged pharmaceutical preparation comprising its salt
ZA793720B (en) Substituted 2-phenylamino-imidazoline-(2)derivatives,acid addition salts thereof,processes for their preparation,and pharmaceutical compositions thereof
GB1359560A (en) Preparation of pyrrylsalicylic acid
IE34648L (en) Pharmaceutical composition containing garcinia acid
GB1187946A (en) Dimethylbiguanide Derivative
IL34468A0 (en) Acid addition salts of indenopyridine derivatives,their preparation and pharmaceutical compositions containing them
GB1421589A (en) Salicylanilide derivatives
KR860000070A (en) Tumor growth inhibitory composition
CA1024988A (en) Derivatives of 4-chloro-5-sulfamoyl-anthranilic acid, their preparation and pharmaceutical compositions comprising them
IL40623A (en) 14,15-dihydro-eburnamine-14-carboxylic acid derivatives and salts thereof,their preparation and pharmaceutical compositions containing them
GB1361779A (en) Vincamine salt and its use as a pharmaceutical composition
IE34386B1 (en) Pharmaceutical compositions
IE38940B1 (en) Pharmaceutical compositions containing p-chlorohippuric acid or salts thereof
CA820860A (en) Pharmaceutical composition containing the hydrochloric acid addition salt of 2-amino-adamantane as active ingredient